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Abstract
Background: This study examined sex-specific differences in physical health-related quality of life (HRQoL) across
subgroups of metabolic health and obesity. We specifically asked whether (1) obesity is related to lower HRQoL
independent of metabolic health status and potential confounders, and (2) whether associations are similar in men
and women.
Methods: We used cross-sectional data from the German Health Interview and Examination Survey 2008–11.
Physical HRQoL was measured using the Short Form-36 version 2 physical component summary (PCS) score. Based
on harmonized ATPIII criteria for the definition of the metabolic health and a body mass index ≥ 30 kg/m2 to
define obesity, individuals were classified as metabolically healthy non-obese (MHNO), metabolically unhealthy
non-obese (MUNO), metabolically healthy obese (MHO), and metabolically unhealthy obese (MUO). Sex-specific
analyses including multivariable linear regression analyses were based on PCS as the dependent variable, metabolic
health and obesity category as the independent variable with three categories and MHNO as the reference, and
age, education, lifestyle and comorbidities as confounders.
Results: This study included 6860 participants (3298 men, 3562 women). Compared to MHNO, all other metabolic
health and obesity categories had significantly lower PCS in both sexes. As reflected by the beta coefficients [95%
confidence interval] from bivariable linear regression models, a significant inverse association with PCS was
strongest for MUO (men: −7.0 [−8.2; −5.8]; women: −9.0 [−10.2; −7.9]), intermediate for MUNO (men: −4.2 [−5.3; −3.
1]; women: −5.6 [−6.8; −4.4]) and least pronounced for MHO (men: −2.2 [−3.6; −0.8]; women −3.9 [−5.4; −2.5]).
Differences in relation to MHNO remained statistically significant for all groups after adjusting for confounders, but
decreased in particular for MUNO (men:–1.3 [−2.3; −0.3]; women: −1.5 [−2.7; −0.3].
Conclusions: Obesity was significantly related to lower physical HRQoL, independent of metabolic health status.
Potential confounders including age, educational status, health-related behaviors, and comorbidities explained parts
of the inverse relationship. Associations were evident in both sexes and consistently more pronounced among
women than men.
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Introduction
Physical health-related quality of life (HRQoL) is a
clinically relevant predictor of adverse health outcomes
e.g. disability [1], cancer, coronary heart disease and all-
cause mortality [2]. Obesity has been associated with
reduced physical HRQoL in numerous studies [3, 4]
with a stronger association in women compared to men
[5–8]. Several recent studies have demonstrated that
even a “metabolically healthy obese” phenotype, i. e.
persons with obesity in the absence of metabolic risk
factors or comorbidities, show reduced scores of phys-
ical HRQoL compared to the group of metabolically
healthy non-obese (MHNO) [9–11]. However, these
previous studies applied different definitions of meta-
bolic health and HRQoL and considered various sub-
sets of potential confounders. Potential confounders of
the association between obesity and lower HRQoL in-
clude higher age, low educational status, health-related
behaviours [12], and chronic health conditions [13]. In
general, metabolic health is associated with higher
HRQoL, however, sex-specific associations are still un-
clear [14]. Previous studies described similar effects
among men and women [15] as well as different associ-
ations among both sexes, with a negative effect of an
impaired health status observed only among women
[14]. To our knowledge only one previous study on
obesity among metabolic health men and women con-
ducted sex-specific analyses and found that metabolic
health had a greater impact on HRQoL than obesity in
men while similar effects for metabolic health and
obesity were seen in women [9].
Against this background the aim of this study was (1) to
determine whether obesity is related to lower HRQoL
independent of metabolic health status also consider-
ing age, low educational status, health-related behav-
iours, and comorbidities as potential confounders, and
(2) whether associations are similar among men and
women.
Methods
Study design and sample
The German Health Interview and Examination Survey
for Adults 2008–11 (DEGS1) is part of the German
health monitoring system. Participants were selected
from local population registries in a two-stage sam-
pling procedure. A sample of 7115 participants had
participated in the examination part and within this
sample representative cross-sectional analyses for the
age range of 18–79 years are possible. Exclusion of
participants with missing data on body mass index
(BMI) and metabolic health status resulted in a study
sample of 6860 participants (3298 men, 3562 women).
The design of DEGS1 has been previously described
in detail [16].
Data collection and study variables
Physical health-related quality of life
A validated self-administered German language version
[17] of the Medical Outcome Short Form-36 version 2
(SF-36 version 2) [18, 19] was used to measure physical
HRQoL. The questionnaire comprises 36 questions cov-
ering eight domains: physical functioning, role-physical,
bodily pain, general health, vitality, social functioning,
role-emotional and mental health [20]. To improve inter-
national comparability “norm-based scoring” was con-
ducted; therefore, the scales were z-transformed using
the average values and standard deviations of the 1998
American normative random sample [21]. Two summary
measures, the physical component summary (PCS) and the
mental component summary combine the information
of the eight scales. The present analysis focussed on the
PCS score, which correlates mostly with the domains
physical functioning, role-physical and bodily pain [20].
Metabolic health and obesity categories
Body weight, body height and waist circumference (WC)
were measured by trained staff [22]. Body weight was
measured using a calibrated electronic scale (SECA,
column scale 930, Hamburg, Germany) with a precision
of 0.1 kg and body height with a portable stadiometer
(Holtain Ltd., UK) with a precision of 0.1 cm. BMI was
calculated as body weight divided by height squared and
categorized as non-obese (BMI < 30 kg/m2) and obese
(BMI ≥ 30 kg/m2) [23]. WC was measured at the min-
imal waist using a flexible, non-stretchable tape. Among
participants with no visible waist, WC was measured at
the midpoint between the lowest rib and the ileac crest.
Blood pressure was measured on the right arm following
a standardized protocol and using an automated os-
cillometric device (Datascope Accutorr Plus) [24]. Self-
reported physician-diagnosed diseases were obtained in
computer-assisted interviews administered by specifically
trained physicians [16]. All medications taken in the 7 days
prior to the interview were documented by trained medical
staff and coded according to the Anatomical Therapeutic
Chemical classification system [25]. Blood samples were
taken and time of blood draw and number of hours since
last meal were recorded [16]. Fasting time was calculated
and considered for serum triglyceride cut-off definitions as
applied in previous studies [26, 27]. Laboratory analyses
were conducted to determine glycated hemoglobin (HbA1c;
immunoturbidimetric method, Architect ci8200), triglycer-
ides (enzymatic procedure, Architect ci8200) and high
density lipoprotein cholesterol (HDL-C; enzymatic proced-
ure, Architect ci8200).
Metabolic health was defined based on the ATPIII
definition [28] as described before for this study
population [27] and as fulfilling three or more of the
following criteria:
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– WC < 88 cm in women and WC < 102 cm in men
– HbA1c < 5.7% and had no drug treatment and no
physician-diagnosed diabetes
– Blood pressure < 130/85 mmHg and had no drug
treatment and no physician-diagnosed hypertension
– Triglycerides < 1.7 mmol/l (or < 2.1 mmol/l
among participants, who fasted less than 8 h)
and had no drug treatment and no physician-
diagnosed dyslipidemia
– HDL-C ≥ 1.0 mmol/l in men and ≥ 1.3 mmol/l
in women
Categories of metabolic health status and obesity were
defined as metabolically healthy non-obese (MHNO),
metabolically unhealthy non-obese (MUNO), metabolic-
ally healthy obese (MHO), and metabolically unhealthy
obese (MUO).
Covariables
Covariables were selected to adjust for potential con-
founders as described in previous studies [9–11]. Educa-
tional status (low, middle, high), smoking (no, occasionally,
daily), physical activity ≥ 2.5 h per week (no, yes) and alco-
hol consumption (never: 0 g, moderate: 0- < 10 g in women
and 0- < 20 g in men, high: ≥ 10 g in women and ≥ 20 g in
men) was assessed by self-administered questionnaires.
Comorbidity was defined as reporting at least one of
the following physician-diagnosed conditions in per-
sonal computer-assisted interviews: cancer, myocardial
infarction, stroke asthma, coronary heart disease, chronic
heart failure, asthma, musculoskeletal conditions. Based
on a question asking for additional diseases requiring
current treatment, self-reported gallbladder disease was
considered as an obesity-related health condition. Detailed
information regarding the definition of covariables is
shown in Additional file 1.
Analysis
In descriptive analyses means, percentages and 95% con-
fidence intervals were calculated in strata of metabolic
health status and obesity categories. All analyses were
stratified for sex. Linear regression analyses were per-
formed with the PCS as dependent variable and categor-
ies of metabolic health and obesity as independent
variable (Model 1). The group of MHNO was used as
the reference category. Model 2 was additionally ad-
justed for age (squared). Model 3 additionally included
alcohol consumption, educational status, physical activ-
ity, smoking, and comorbidity. In a sensitivity analysis
linear regression analyses were performed with the phys-
ical functioning score as dependent variable because the
association between BMI and HRQoL seems to be most
pronounced in this domain [29]. In linear regression
analyses gender differences in PCS were identified in
categories of metabolic health and obesity. The level of
statistical significance was set at p = 0.05 based on two-
sided tests. SAS 9.4 survey procedures (SAS Institute
Inc., Cary, NC) were used for all statistical analyses. To
account for the clustered survey design specific survey
procedures were used. Analyses were weighted using a
weighting factor to correct for deviations of the net
sample from the population structure in Germany and
compensate for stratification.
Results
Table 1 (men) and Table 2 (women) present the study
characteristics by strata of metabolic health status and
obesity. In men the distribution of participants was
MHNO (n = 1900), MUNO (n = 608), MHO (n = 196),
MUO (n = 594) and in women it was MHNO
(n = 2193), MUNO (n = 514), MHO (n = 277), MUO
(n = 578). MHNO (mean age men: 42.1 years, women:
42.4 years) were younger than MHO and MUO; MUNO
(men: 55.6 years, 59.3 years) was the oldest group. Per-
centage of low educational status was lowest in MHNO
(men: 30.7%, women: 27.8%) and highest in MUO (men:
51.3%, women: 59.5%). Percentages of daily smoking and
physical activity ≥ 2.5 h were lower among metabolically
unhealthy men and women. Percentages of high alcohol
consumption were highest among MUNO for men
(22.7%) and highest among MHNO for women (14.9%).
The prevalence of comorbidities was higher among
metabolically unhealthy men and women. The PCS was
highest among MHNO (men: 54.0, women: 53.1) and
lowest among MUO (men: 47.0, women: 44.1).
Table 3 shows the PCS in relation to categories of
metabolic health and obesity for men and women. Add-
itionally, Table S1 (Additional file 2) presents the estima-
tions for physical functioning. Compared with MHNO,
all other categories of metabolic health and obesity were
consistently associated with lower PCS values among
men and among women. The inverse association with
PCS was strongest for MUO (men: −7.0, women: −9.0),
intermediate for MUNO (men: −4.2, women: −5.6) and
least pronounced for MHO (men: −2.2, women −3.9.
Adjusting for age (Model 2) and further adjustment for
sociodemographic characteristics, lifestyle variables and
comorbidities (Model 3) decreased the association
among all strata of metabolic health and obesity. After
adjusting for confounding variables, the effect was
strongest for MUO (men: −3.9, women: −4.9), inter-
mediate for MHO (men: −1.8, women: −2.1) and least
pronounced for MUNO (men: −1.3, women: −1.5). The
results for the PCS were similar to the results found in
sensitivity analyses using the physical functioning score
as dependent variable (Additional file 2: Table S1).
Table 4 presents gender differences in PCS for cat-
egories of metabolic health and obesity status. PCS
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scores were consistently lower among women com-
pared to men in all strata. Gender differences were
lowest among MHNO (−0.9) and highest among
MUO (−2.9). After adjusting for confounding vari-
ables differences remained statistically significant only
among MHNO.
Discussion
Obesity and metabolic aberration alone and in combin-
ation were associated with impaired physical HRQoL in
both sexes. The effect of both factors in combination
corresponds approximately to the effects for obesity and
metabolic aberration alone. These results underline









Age (mean, years) 0 42.1 (41.3–42.9) 56.8 (55.2–58.4) 44.4 (42.3–46.6) 55.6 (54.2–57.1)
Educational status (%) 21
Low 30.7 (27.5–34.0) 41.3 (35.8–47.0) 41.2 (32.3–50.7) 51.3 (45.5–57.2)
Middle 51.3 (48.4–54.2) 38.8 (33.9–43.8) 48.3 (39.3–57.4) 38.3 (32.7–44.1)
High 18.0 (15.9–20.4) 20.0 (16.0–24.6) 10.5 (6.7–16.0) 10.4 (8.0–13.5)
Smoking (%) 17
No 64.1 (60.9–67.2) 74.0 (68.1–79.2) 66.8 (57.0–75.4) 72.1 (66.7–76.9)
Occasionally 7.5 (6.2–9.1) 4.3 (2.5–7.3) 5.9 (3.4–10.3) 5.6 (3.6–8.7)
Daily 28.4 (25.6–31.4) 21.7 (17.0–27.2) 27.3 (18.9–37.6) 22.3 (17.9–27.6)
Physical activity ≥ 2.5 h (%) 116 28.2 (25.5–31.0) 18.4 (14.6–22.9) 30.0 (22.5–38.6) 18.9 (15.0–23.4)
Alcohol consumption (%) 55
Never 10.4 (8.4–12.8) 8.4 (5.8–11.9) 11.3 (6.7–18.3) 9.2 (6.2–13.3)
Moderate 72.0 (69.1–74.8) 68.9 (64.9–72.7) 72.6 (63.7–80.0) 71.5 (65.9–76.4)
High 17.6 (15.6–19.8) 22.7 (19.3–26.5) 16.1 (10.7–23.4) 19.4 (15.4–24.1)
One or more comorbidities (%) 29 25.7 (23.2–28.3) 51.9 (46.8–57.0) 25.7 (23.2–28.3) 49.5 (44.1–54.9)
Physical component summary (mean)a 158 54.0 (53.6–54.5) 49.8 (48.8–50.9) 51.8 (50.4–53.3) 47.0 (45.9–48.2)
MHNO metabolically healthy non-obese, MUNO metabolically unhealthy non-obese, MHO metabolically healthy obese, MUO metabolically unhealthy obese
aPhysical Health Related Quality of Life according to SF36v2









Age (mean, years) 0 42.4 (41.7–43.1) 61.9 (60.6–63.3) 47.0 (45.0–48.9) 59.3 (57.8–60.8)
Educational status (%) 17
Low 27.8 (25.3–30.6) 55.9 (49.9–61.8) 45.1 (37.0–53.4) 59.5 (53.8–65.0)
Middle 56.2 (53.3–59.1) 36.0 (30.3–42.1) 49.9 (42.0–57.9) 36.5 (31.4–41.9)
High 16.0 (13.6–18.6) 8.1 (6.1–10.7) 5.0 (3.1–8.0) 4.0 (2.5–6.2)
Smoking (%) 17
No 69.9 (67.0–72.7) 78.9 (73.4–83.5) 74.5 (67.8–80.3) 79.1 (74.3–83.2)
Occasionally 7.7 (6.4–9.2) 2.1 (1.1–4.1) 4.1 (2.1–7.7) 1.5 (0.7–3.3)
Daily 22.4 (20.0–25.0) 19.0 (14.8–24.1) 21.4 (16.1–27.9) 19.4 (15.5–24.1)
Physical activity ≥ 2.5 h (%) 110 15.9 (14.1–18.0) 13.7 (10.3–18.1) 16.9 (12.0–23.2) 14.0 (10.5–18.4)
Alcohol consumption (%) 44
Never 16.3 (14.5–18.3) 17.0 (13.0–21.8) 21.0 (15.6–27.8) 29.7 (25.1–34.7)
Moderate 68.8 (66.2–71.3) 70.8 (65.3–75.8) 68.9 (60.7–76.1) 61.1 (55.8–66.1)
High 14.9 (13.1–16.9) 12.2 (8.8–16.8) 10.0 (5.5–17.4) 9.2 (6.2–13.6)
One or more comorbidities (%) 22 26.0 (23.7–28.6) 54.6 (49.4–59.7) 40.2 (34.0–46.7) 59.9 (54.7–64.9)
Physical component summary (mean)a 150 53.1 (52.7–53.6) 47.6 (46.4–48.7) 49.2 (47.8–50.6) 44.1 (43.1–45.1)
MHNO metabolically healthy non-obese, MUNO metabolically unhealthy non-obese, MHO metabolically healthy obese, MUO metabolically unhealthy obese
aPhysical Health Related Quality of Life according to SF36v2
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previous findings suggesting that MHO individuals are
not always completely healthy with regard to HRQoL
[10, 11] as well as morbidity of cardiovascular diseases
[30, 31] and all-cause mortality [32, 33]. A recent clinical
study found similar levels of HRQoL among MHO and
MUO individuals [34]. This finding seems to contrast
with our results with larger effects of MUO vs. MHNO
compared to MHO vs. MHNO. The discrepancies may
be caused by the clinical setting as patients who are
willing to be treated probably are likely to suffer from
obesity. However, in conclusion both studies support the
finding that MHO is not a healthy state.
The association between physical HRQoL, metabolic
health and obesity categories is stronger among women,
as lower PCS values were found in all strata of metabolic
health and obesity among women compared to men.
Furthermore, differences between strata were greater
among women than among men. Lower values of
physical HRQoL among women compared to men were
also reported in previous studies analysing the associ-
ation with obesity [7, 8] and obesity in combination with
metabolic health [9, 10] opposed to one meta-analysis
where no gender differences were found [3]. In the
present study, adjustment for potential confounders in-
cluding education, health-related behaviours and comor-
bidities gender differences were attenuated. Thus, lower
HRQoL among women than men might be partially ex-
plained by sex-differences in the prevalence of obesity-
related comorbidities [35] and health-related behaviours
e.g. physical activity [36]. Among both, men and women
physical HRQoL was highest for the MHNO group
followed by MHO and MUNO and lowest for the group
of MUO. This is in contrast to findings of a Korean
cross-sectional study [9], where HRQoL were measured
using the euroqol-5 dimensions questionnaire. Among
Korean men physical HRQoL was lowest among the
group of MUNO, suggesting that an unhealthy meta-
bolic status have a greater impact than obesity. In this
previous study, no differences in physical HRQoL were
observed between groups of metabolic status and obes-
ity among men after adjusting for age, sociodemo-
graphic variables, lifestyle and comorbidity. Among
Korean women, the results were similar to the findings
of our study.
Persons in the different categories of obesity and meta-
bolic health status substantially differed according to
mean age, educational status and prevalence of one or
more comorbidities. Previous studies reported lower
values of HRQoL at higher age, among persons with
chronic diseases, and in low educational status groups
[13, 21, 37, 38]. Considering these potential confounders
in multivariable regression analyses in the present study
Table 3 Linear regression models for physical component summary (SF-36 v2) according to metabolic health and obesity status
N MHNO MUNO MHO MUO
Beta Lower CL Upper CL p Beta Lower CL Upper CL p Beta Lower CL Upper CL p
Men
Model 1 3140 Reference −4.2 −5.3 −3.1 <.001 −2.2 −3.6 −0.8 .003 −7.0 −8.2 −5.8 <.001
Model 2 3140 Reference −1.7 −2.7 −0.6 .002 −1.9 −3.3 −0.5 .006 −4.7 −5.9 −3.5 <.001
Model 3 2988 Reference −1.3 −2.3 −0.3 .014 −1.8 −3.1 −0.5 .009 −3.9 −5.1 −2.7 <.001
Women
Model 1 3412 Reference −5.6 −6.8 −4.4 <.001 −3.9 −5.4 −2.5 <.001 −9.0 −10.2 −7.9 <.001
Model 2 3412 Reference −2.1 −3.3 −0.9 <.001 −3.3 −4.7 −1.9 <.001 −6.2 −7.4 −5.0 <.001
Model 3 3270 Reference −1.5 −2.7 −0.3 .018 −2.1 −3.2 −1.0 <.001 −4.9 −6.1 −3.6 <.001
Model 1: unadjusted
Model 2: adjusted for age (squared)
Model 3: additionally adjusted for educational status, smoking, physical activity, alcohol consumption, comorbidities
CL confidence limit, MHNO metabolically healthy non-obese, MUNO metabolically unhealthy non-obese, MHO metabolically healthy obese, MUO metabolically
unhealthy obese
Table 4 Gender differences (reference = men) in physical component summary (SF-36 v2) in categories of metabolic health and
obesity status
MHNO N = 3945 MUNO N = 1064 MHO N = 457 MUO N = 1084
Beta Lower CL Upper CL p Beta Lower CL Upper CL p Beta Lower CL Upper CL P Beta Lower CL Upper CL p
Model 1 −0.9 −1.5 −0.2 .007 −2.3 −3.7 −0.8 .003 −2.7 −4.8 −0.5 .014 −2.9 −4.5 −1.4 <.001
Model 2 −0.8 −1.5 −0.2 .008 −1.1 −2.4 0.2 .084 −2.1 −4.2 −0.1 .043 −2.3 −3.7 −0.8 .003
Model 3 −0.8 −1.4 −0.1 .019 −1.0 −2.4 0.3 .130 −1.2 −3.1 0.6 .200 −1.1 −2.6 0.5 .180
Model 1: unadjusted
Model 2: adjusted for age (squared)
Model 3: additionally adjusted for educational status, smoking, physical activity, alcohol consumption, comorbidities
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reduced the effect of lower physical HRQoL among all
strata of metabolic health and obesity status compared
to MHNO, but remained statistically significant among
both sexes. A difference of two to three points in the
PCS is considered clinically relevant [20]. Thus, after
adjusting for confounding variables lower values of
physical HRQoL among MHO compared to MHNO
remained clinically relevant only among women. Adjust-
ment for confounding factors had the largest impact
among MUNO as differences in comparison to MHNO
do not remain clinically significant.
The strength of this study is its large sample of the
general population which allows stratification for gender
and adjustment for potential confounding variables.
Furthermore, anthropometric parameters were measured
by standard protocols and trained staff and valid data
collection tools were used to assess physical HRQoL,
diseases, and various health determinants, and biological
parameters. A few limitations have to be acknowledged.
Since this is a cross-sectional study the direction of the
causal pathway between physical HRQoL and metabolic
health according to obesity category cannot be identified.
Poorer physical HRQoL, characterized by sedentary be-
haviour, might increase weight gain and vice versa. Due
to the study design we used different cut-offs among
fasting and non-fasting participants for serum glucose
and triglycerides. Finally, bias due to misclassification
cannot be ruled out completely.
Conclusion
Obesity was significantly related to lower physical
HRQoL, independent of metabolic health status, which
underlines previous findings that MHO status is not
necessarily a healthy state. This inverse relationship can
be partly explained by age, educational status, health-
related behaviors, and comorbidities. The associations
were found in both sexes and were consistently more
pronounced among women compared to men.
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